Advanced search
Publication Cover
Postgraduate Medicine Volume 123, 2011 - Issue 1
Submit an article Journal homepage
59
Views
15
CrossRef citations to date
0
Altmetric
Clinical Focus: Metabolic Disorders, Diabetes, and Cardiovascular Disease

A Randomized, Double-Blind, Forced-Titration Study to Compare Olmesartan Medoxomil versus Losartan Potassium in Patients with Stage 1 and 2 Hypertension

Matthew R. Weir Professor and Director, Division of Nephrology, University of Maryland School of Medicine, Baltimore, MDCorrespondence[email protected]
, MD,
Henry A. Punzi Medical Director, Trinity Hypertension and Metabolic Research Institute, Carrollton, TX
, MD,
John M. Flack Chair, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI
, MD, MPH,
Kathy A. Stoakes Manager, Medical Research and Strategy, Daiichi Sankyo, Inc., Parsippany, NJ
, RN, BSN,
Kathleen J. Chavanu Director, Scientific Communications, Daiichi Sankyo, Inc., Parsippany, NJ
, PharmD,
Wei Li Principal Biostatistician, Medical Affairs, Daiichi Sankyo, Inc., Parsippany, NJ
, PhD &
Robert Dubiel Director, Medical Affairs, Daiichi Sankyo, Inc., Parsippany, NJ
, PharmD show all
Pages 80-87 | Published online: 13 Mar 2015

References

  • . Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):2043–2050
  • . Israili ZH. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens. 2000;14 suppl 1:S73–S86
  • . Giles TD, Oparil S, Silfani TN, Wang A, Walker JF. Comparison of increasing doses of olmesartan medoxomil, losartan potassium, and valsartan in patients with essential hypertension. J Clin Hypertens (Greenwich). 2007;9(3):187–195
  • . Oparil S, Williams D, Chrysant SG, Marbury TC, Neutel J. Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension. J Clin Hypertens (Greenwich). 2001;3(5): 283–291, 318
  • . Le MT, Pugsley MK, Vauquelin G, Van Liefde I. Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor. Br J Pharmacol. 2007;151(7):952–962
  • . Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913
  • . Dahlof B, Devereux RB, Kjeldsen SE, . Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995–1003
  • . White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit. 2001;6(2):63–72
  • . Pickering TG, Hall JE, Appel LJ, . Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697–716
  • . Oparil S, Silfani TN, Walker JF. Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals. Am J Hypertens. 2005;18(2 pt 1):287–294
  • . Iskedjian M, Einarson TR, MacKeigan LD, . Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002;24(2):302–316

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.